These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21554718)
21. Antihyperalgesic effect of CB Oliveira-Fusaro MCG; Zanoni CIS; Dos Santos GG; Manzo LP; Araldi D; Bonet IJM; Tambeli CH; Dias EV; Parada CA Eur J Pharmacol; 2017 Mar; 798():113-121. PubMed ID: 28131783 [TBL] [Abstract][Full Text] [Related]
22. Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H Grundy L; Caldwell A; Garcia Caraballo S; Erickson A; Schober G; Castro J; Harrington AM; Brierley SM Am J Physiol Renal Physiol; 2020 Feb; 318(2):F298-F314. PubMed ID: 31790304 [TBL] [Abstract][Full Text] [Related]
23. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. Dinis P; Charrua A; Avelino A; Yaqoob M; Bevan S; Nagy I; Cruz F J Neurosci; 2004 Dec; 24(50):11253-63. PubMed ID: 15601931 [TBL] [Abstract][Full Text] [Related]
24. TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release. Weller K; Reeh PW; Sauer SK Neuropeptides; 2011 Dec; 45(6):391-400. PubMed ID: 21868092 [TBL] [Abstract][Full Text] [Related]
25. Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats. Strittmatter F; Gandaglia G; Benigni F; Bettiga A; Rigatti P; Montorsi F; Gratzke C; Stief C; Colciago G; Hedlund P Eur Urol; 2012 Jan; 61(1):98-106. PubMed ID: 21930339 [TBL] [Abstract][Full Text] [Related]
26. Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. Bakali E; Mbaki Y; Lambert DG; Elliott RA; Mason R; Tincello DG Int Urogynecol J; 2016 Sep; 27(9):1393-400. PubMed ID: 26942594 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat. Aizawa N; Hedlund P; Füllhase C; Ito H; Homma Y; Igawa Y J Urol; 2014 Sep; 192(3):956-63. PubMed ID: 24746881 [TBL] [Abstract][Full Text] [Related]
28. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273 [TBL] [Abstract][Full Text] [Related]
29. Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro. Campeau L; Füllhase C; Sawada N; Gratzke C; Hedlund P; Howlett AC; Andersson KE Neurourol Urodyn; 2014 Jun; 33(5):566-70. PubMed ID: 23908133 [TBL] [Abstract][Full Text] [Related]
31. Effects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat. Yu Y; de Groat WC Brain Res; 2010 Nov; 1361():43-53. PubMed ID: 20840844 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816 [TBL] [Abstract][Full Text] [Related]
33. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide. Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Chin CL; Tovcimak AE; Hradil VP; Seifert TR; Hollingsworth PR; Chandran P; Zhu CZ; Gauvin D; Pai M; Wetter J; Hsieh GC; Honore P; Frost JM; Dart MJ; Meyer MD; Yao BB; Cox BF; Fox GB Br J Pharmacol; 2008 Jan; 153(2):367-79. PubMed ID: 17965748 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model. Li Y; Sun Y; Zhang Z; Feng X; Meng H; Li S; Zhu Y; Chen S; Wang Y; Wang J; Zhang D; Jiang X; Li N; Shi B BJU Int; 2013 Jul; 112(2):E143-50. PubMed ID: 23795792 [TBL] [Abstract][Full Text] [Related]
36. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder. Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490 [TBL] [Abstract][Full Text] [Related]
37. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008 [TBL] [Abstract][Full Text] [Related]
38. TRPV1 enhances the afferent response to P2X receptor activation in the mouse urinary bladder. Grundy L; Daly DM; Chapple C; Grundy D; Chess-Williams R Sci Rep; 2018 Jan; 8(1):197. PubMed ID: 29317663 [TBL] [Abstract][Full Text] [Related]
39. Effects of nicotinic receptor agonists on bladder afferent nerve activity in an in vitro bladder-pelvic nerve preparation. Yu Y; Daugherty SL; de Groat WC Brain Res; 2016 Apr; 1637():91-101. PubMed ID: 26876739 [TBL] [Abstract][Full Text] [Related]
40. Opposite effects of cannabinoid CB Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]